Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange Other stock markets 10:30:00 16/07/2026 +04			5-day change	1st Jan Change
2,300.50 ^JPY	+0.61%		+3.35%	-5.37%

06-22	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI
05-27	ReeNT Co., Ltd. announced that it expects to receive ¥600 million in funding from Alfresa Holdings Corporation	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	403,531	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-12.16%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	403,531	403,531	403,531
Change	-	11%	26.5%	2.46%	24.61%	33.65%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	17.6x	14.1x	14.8x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.8x	0.76x	0.76x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.6x	-2.99x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.13x	0.12x	0.12x
EV / Revenue	0x	0x	0x	0x	0x	0.13x	0.12x	0.12x
EV / EBITDA	0x	0x	0x	0x	0x	7.89x	7.72x	7.6x
EV / EBIT	0x	0x	0x	0x	0x	11x	10.5x	10.4x
EV / FCF	0x	-0x	0x	-0x	0x	18.3x	24.7x	31x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.45%	4.05%	3.22%
Dividend per Share ²	54	57	70	63	68	71	79	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.11%	3.46%	3.72%
EPS ²	153.6	127.4	154.1	147.5	229.6	130	162.3	154.2
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	54.6%	48.7%	55.1%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,164,453	3,252,695	3,296,209
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	51,122	52,276	53,122
EBIT ¹	29,091	30,148	38,460	38,080	36,164	36,682	38,362	38,676
Net income ¹	32,182	25,786	29,558	27,389	41,746	25,246	28,121	27,578
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,286.50	2,286.50	2,286.50
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,410	-	-
Announcement Date	16/05/22	15/05/23	14/05/24	15/05/25	15/05/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALFRESA HOLDINGS CORPORATION	17.59x	-	-	3.11%	2.47B
ABBOTT LABORATORIES	22.34x	3.25x	12.12x	2.86%	155B
MEDTRONIC PLC	18.26x	3.22x	11.31x	3.69%	103B
CENCORA, INC.	16.5x	0.18x	11.68x	0.8%	57.7B
HOYA CORPORATION	31.96x	7.77x	20.31x	1.25%	52.27B
BECTON, DICKINSON AND COMPANY	38.59x	3.08x	10.51x	2.49%	42.68B
MEDLINE INC.	37.81x	1.38x	12.14x	0.26%	33.35B
DEXCOM, INC.	29.71x	5.26x	16.78x	-.--%	28.06B
WEST PHARMACEUTICAL SERVICES, INC.	42.66x	7.46x	26.92x	0.24%	25.36B
SARTORIUS STEDIM BIOTECH	48.05x	6.45x	20.7x	0.45%	21.03B
Average	30.35x	4.23x	15.83x	1.52%	52.14B
Weighted average by Cap.	26.57x	3.67x	13.92x	2.06%